Our Why
Anne T.
Clinical trial
patient
In 2003, Anne was
diagnosed with
Myelodysplasia
5q-, a rare bone
marrow disorder
that affects the development of red blood cells,
often leading to anemia and enlarged red blood
cells. At that time, her care provider told her she
likely had only five years to live. Fortunately, through
a support group, she learned of a clinical trial
offered by Gustavo A. Fonseca, MD, FACP,
(Lecanto), and was qualified to enroll.
Now, 20 years later, Ann has experienced
many milestones since her diagnosis and
extends her gratitude to Dr. Fonseca, her
FCS care team, and above all, the clinical
trial that saved her life.
Our Mission
Centered on you, inspired by hope, powered
by science and innovation.
Our Vision
To be the world-class provider of cancer
care, delivering innovation, excellence and
a personalized experience to patients in the
communities we live and serve.
Our PACT Values
Patient First
Keeping the patient at the center of
everything we do
Accountability
Taking responsibility for our actions
Commitment & Care
Upholding FCS vision through every action
Team
Working together, one team, one mission
20 Years Later:
A Testament to Trust and
Transformative Care
Watch Anne's
full story
One Team.
One Mission.
Executive Board
Alexander
Glick, MD
Matthew A.
Fink, MD
David
Wenk, MD
Lucio N.
Gordan, MD
Joel S.
Grossman, MD
Don D.
Luong, MD
Mary M.
Li, MD, PhD
Sachin
Kamath, MD
Maen
Hussein, MD
Anjan J.
Patel, MD
Frank
Rodriguez, MD
Shachar
Peles, MD
Paresh
Patel, MD
Hitesh
Patel, MD
Andres O.
Soriano, MD
Our Executive Board members play an integral
role in ensuring that we ful�ll our mission and
maintain the highest ethical and clinical standards.